Multivitamins improve weight gain patterns during pregnancy in HIV-infected women from Tanzania

October 24, 2002

Maternal HIV infection is a particular problem of sub-Saharan Africa, where > 13 million women of childbearing age are infected. Pregnant women who are HIV positive are at serious risk for low birth weight infants or preterm delivery. The progression of HIV infection is usually accompanied by opportunistic infections, diminished dietary intake, and nutrient malabsorption, resulting in weight loss. In an article appearing in the American Journal of Clinical Nutrition, Villamor et al. studied a large group of pregnant, HIV positive women from Dar es Salaam, Tanzania and the effects that several different regimes of multivitamin supplement had on their pregnancy outcomes. They found that, during the third trimester, women who took multivitamins gained significantly more weight than women who did not.

Nine hundred and fifty-seven pregnant HIV-positive women who were between 12 and 27 weeks of gestation were enrolled at 4 clinics in Tanzania. The women averaged 25 years old, with an average weight of 57 kg at their first clinic visit. They were randomly assigned to participate in 1 of 4 regimes: a multivitamin supplement that did not include vitamin A; a vitamin A-alone supplement; a multivitamin supplement that included vitamin A; or, a placebo. During the third trimester, multivitamin use was associated with a small increase in weight gain (averaging 304 g) when compared to the placebo. The risk of weight loss or low weight gain after 26 weeks of gestation was 30% less among women who took multivitamins. Though there was no positive overall association between vitamin A and weight gain, women who received both vitamin A and a multivitamin gained more weight in the second trimester than any of the other groups, and had a 29% lower risk of low weight gain at term.

The authors suggest that multivitamins may possibly improve weight loss patterns in pregnant women by slowing the progression of HIV disease, or by reducing the incidence and severity of secondary infections. The prevention of weight loss is an essential goal of multivitamin supplementation in HIV-infected women because fewer instances of fetal loss, prematurity, intrauterine growth retardation, and infant and maternal mortality will occur.
Villamor, Eduardo. Effect of multivitamin and vitamin A supplements on weight gain during pregnancy among HIV-1-infected women. Am J Clin Nutr 2002;76:1082-90.

This media release is provided by The American Society for Clinical Nutrition to provide current information on nutrition-related research. This information should not be construed as medical advice. If you have a medical concern, consult your doctor. To see the complete text of this article, please go to:

For more information, please contact:

American Journal of Clinical Nutrition

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to